Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Kristina, Iribarren"'
Autor:
Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, Kristina Iribarren, Juliette Humeau, Jonathan G. Pol, Sarah Levesque, Laura Mondragon, Takahiro Yamazaki, Ai Sato, Fernando Aranda, Sylvère Durand, Alexandre Boissonnas, Jitka Fucikova, Laura Senovilla, David Enot, Michal Hensler, Margerie Kremer, Gautier Stoll, Yang Hu, Chiara Massa, Silvia C. Formenti, Barbara Seliger, Olivier Elemento, Radek Spisek, Fabrice André, Laurence Zitvogel, Suzette Delaloge, Guido Kroemer, Lorenzo Galluzzi
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-18 (2020)
Current preclinical models to investigate human HR + breast cancer progression and response to immunotherapy in vivo are limited. Here, the authors demonstrate that mammary tumours driven by a synthetic progestin combined with an oral carcinogen reca
Externí odkaz:
https://doaj.org/article/a7e37a6ac2cb4091b97dc956fd1c341a
Autor:
Peng Liu, Liwei Zhao, Jonathan Pol, Sarah Levesque, Adriana Petrazzuolo, Christina Pfirschke, Camilla Engblom, Steffen Rickelt, Takahiro Yamazaki, Kristina Iribarren, Laura Senovilla, Lucillia Bezu, Erika Vacchelli, Valentina Sica, Andréa Melis, Tiffany Martin, Lin Xia, Heng Yang, Qingqing Li, Jinfeng Chen, Sylvère Durand, Fanny Aprahamian, Deborah Lefevre, Sophie Broutin, Angelo Paci, Amaury Bongers, Veronique Minard-Colin, Eric Tartour, Laurence Zitvogel, Lionel Apetoh, Yuting Ma, Mikael J. Pittet, Oliver Kepp, Guido Kroemer
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-17 (2019)
Certain chemotherapeutic agents can exert their anticancer effect through indirect immune-dependent mechanism. Here, the authors screen a library of tyrosine kinase inhibitors and show that crizotinib is an effective stimulator of immunogenic cell de
Externí odkaz:
https://doaj.org/article/228ee56caf814e7fbcca341ed093aaed
Autor:
Wei Xie, Sabrina Forveille, Kristina Iribarren, Allan Sauvat, Laura Senovilla, Yan Wang, Juliette Humeau, Maria Perez-Lanzon, Heng Zhou, Juan F. Martínez-Leal, Guido Kroemer, Oliver Kepp
Publikováno v:
OncoImmunology, Vol 8, Iss 11 (2019)
Systemic treatment with the active transcription inhibitor lurbinectedin aims at inducing tumor cell death in hyperproliferative neoplasms. Here we show that cell death induced by lurbinectedin reinstates and enhances systemic anticancer immune respo
Externí odkaz:
https://doaj.org/article/5ca8e05fb4d14608aac3d9432beefce4
Autor:
Kristina Iribarren, Aitziber Buque, Laura Mondragon, Wei Xie, Sarah Lévesque, Jonathan Pol, Laurence Zitvogel, Oliver Kepp, Guido Kroemer
Publikováno v:
OncoImmunology, Vol 8, Iss 3 (2019)
The treatment of breast cancer largely depends on the utilization of immunogenic chemotherapeutics, which, as a common leitmotif, stimulate the exposure of calreticulin (CALR) on the surface of cancer cells, thereby facilitating their recognition by
Externí odkaz:
https://doaj.org/article/ca61c5d614944afebb000f73416ddb1d
Autor:
Marion Dajon, Kristina Iribarren, Florent Petitprez, Solenne Marmier, Audrey Lupo, Mélanie Gillard, Hanane Ouakrim, Navas Victor, Di Bartolo Vincenzo, Pierre Emmanuel Joubert, Oliver Kepp, Guido Kroemer, Marco Alifano, Diane Damotte, Isabelle Cremer
Publikováno v:
OncoImmunology, Vol 8, Iss 1 (2019)
In non-small cell lung carcinoma (NSCLC), stimulation of toll-like receptor 7 (TLR7), a receptor for single stranded RNA, is linked to tumor progression and resistance to anticancer chemotherapy. However, the mechanism of this effect has been elusive
Externí odkaz:
https://doaj.org/article/3d8711a3d69047dc912aa59845b4beaa
Autor:
Alexandre Ivagnès, Meriem Messaoudene, Gautier Stoll, Bertrand Routy, Aurélie Fluckiger, Takahiro Yamazaki, Kristina Iribarren, Connie P. M. Duong, Laetitia Fend, Anne Caignard, Isabelle Cremer, Axel LeCesne, Julien Adam, Charles Honoré, Olivier Mir, Loïc Chaigneau, Anne Berger, Pierre Validire, Christos Christidis, Valérie Le Brun-Ly, Mark J. Smyth, Xavier Mariette, Benoît L. Salomon, Guido Kroemer, Sylvie Rusakiewicz, Laurence Zitvogel
Publikováno v:
OncoImmunology, Vol 7, Iss 12 (2018)
Natural Killer (NK) cells control metastatic dissemination of murine tumors and are an important prognostic factor in several human malignancies. However, tumor cells hijack many of the NK cell functional features compromising their tumoricidal activ
Externí odkaz:
https://doaj.org/article/827dd603e2a54f17ad4e4777d94b2028
Autor:
Isabelle Cremer, Catherine Sautès-Fridman, Wolf Herman Fridman, Marie Caroline Dieu-Nosjean, Mohammad Younes, Sandrine Katsahian, Jeremy Goc, Julien Cherfils-Vicini, Audrey Lupo, Marco Alifano, Catherine Schramm, Kristina Iribarren, Diane Damotte, Lucile Crozet, Saradiya Chatterjee
Toll-like receptors (TLR) recognize pathogen molecules and danger-associated signals that stimulate inflammatory processes. TLRs have been studied mainly in antigen-presenting cells, where they exert important immune regulatory functions, but they ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9359dac9dafed6fedaa8a3cee7ed7d4
https://doi.org/10.1158/0008-5472.c.6505784
https://doi.org/10.1158/0008-5472.c.6505784
Autor:
Isabelle Cremer, Catherine Sautès-Fridman, Wolf Herman Fridman, Marie Caroline Dieu-Nosjean, Mohammad Younes, Sandrine Katsahian, Jeremy Goc, Julien Cherfils-Vicini, Audrey Lupo, Marco Alifano, Catherine Schramm, Kristina Iribarren, Diane Damotte, Lucile Crozet, Saradiya Chatterjee
Supplemental Figures 1-10. Supplementary figure 1 shows that TLR7 antagonist IRS661 specifically blocks TLR7 expression by human A549 cells Supplementary figure 2 shows that TLR7 agonist induces chemoresistance in murine LL/2 cells Supplementary figu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4781db693d3e56e379337e084d5ca1b0
https://doi.org/10.1158/0008-5472.22401206
https://doi.org/10.1158/0008-5472.22401206
Autor:
Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, Kristina Iribarren, Juliette Humeau, Jonathan G. Pol, Sarah Levesque, Laura Mondragon, Takahiro Yamazaki, Ai Sato, Fernando Aranda, Sylvère Durand, Alexandre Boissonnas, Jitka Fucikova, Laura Senovilla, David Enot, Michal Hensler, Margerie Kremer, Gautier Stoll, Yang Hu, Chiara Massa, Silvia C. Formenti, Barbara Seliger, Olivier Elemento, Radek Spisek, Fabrice André, Laurence Zitvogel, Suzette Delaloge, Guido Kroemer, Lorenzo Galluzzi
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Externí odkaz:
https://doaj.org/article/cc7116fe4c254c818613238f917e2b94
Publikováno v:
OncoImmunology, Vol 7, Iss 6 (2018)
A systematic search for anticancer agents that may induce the release of high mobility group box 1 (HMGB1) protein from cells into the extracellular space has led to the identification of several drugs capable of elevating plasma HMGB1 levels in vivo
Externí odkaz:
https://doaj.org/article/62215a4f46544b1ea15f0dff88279220